Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab
PIRA occurs in the context of suboptimal B-cell depletion in RMS patients, highlighting the need for close monitoring and potential adjustment of infusion intervals.
Authors
- Luisa Klotz (ORCID: https://orcid.org/0000-0001-5439-9633)
- Jan D. Lünemann (ORCID: https://orcid.org/0000-0002-3007-708X)
- Catharina Korsukewitz
- Maria Eveslage (ORCID: https://orcid.org/0000-0002-8802-1134)
- Johanna Grosch
- Heinz Wiendl (ORCID: https://orcid.org/0000-0003-4310-3432)
- Susan Trümpelmann
- Andreas Schulte‐Mecklenbeck (ORCID: https://orcid.org/0000-0003-3855-4706)
- Catharina C. Groß (ORCID: https://orcid.org/0000-0002-4872-9189)
- Valerie E. Teschner
- Lisa Revie (ORCID: https://orcid.org/0000-0003-4911-6883)
- Annika Jürjens
Institutions
- University of Münster (DE)
- University Hospital Münster (DE)
Publication Details
- Journal
- Multiple Sclerosis Journal
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1177/13524585251329849
- Citations
- 4
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.89